K. Thompson

发表

Antibacterial Activity of Enrofloxacin and Ciprofloxacin Derivatives of β‐Octaarginine

D. Seebach, J. Leeds, A. Beck, 2015, Chemistry & biodiversity.

Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria.

Sarah L. Williams, D. Bussiere, X. Ling, 2021, Journal of medicinal chemistry.

Molecular Probes for the Determination of Subcellular Compound Exposure Profiles in Gram-Negative Bacteria.

Brian Y Feng, David A Six, F. Reck, 2018, ACS infectious diseases.

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria.

Sarah L. Williams, D. Bussiere, Sylvia Ma, 2020, Journal of medicinal chemistry.

Nonspecific Effect of Mycograb on Amphotericin B MIC

M. Ghannoum, N. Ryder, N. Isham, 2012, Antimicrobial Agents and Chemotherapy.

Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.

W. Shu, C. Bellamacina, G. Tonn, 2018, Journal of medicinal chemistry.

In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor

Sylvia Ma, J. Leeds, C. Dean, 2022, Antimicrobial agents and chemotherapy.

Mutations Reducing In Vitro Susceptibility to Novel LpxC Inhibitors in Pseudomonas aeruginosa and Interplay of Efflux and Nonefflux Mechanisms

J. Walker, C. Dean, S. W. Barnes, 2019, Antimicrobial Agents and Chemotherapy.

Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents

S. Schuierer, J. Tallarico, R. Riedl, 2013, Antimicrobial Agents and Chemotherapy.